Semrad, T. J., Gandara, D. R., & Lara, P. N. (2011). Enhancing the clinical activity of sorafenib through dose escalation: Rationale and current experience. SAGE Publications.
Citación estilo ChicagoSemrad, Thomas J., David R. Gandara, y Primo N. Lara. Enhancing the Clinical Activity of Sorafenib Through Dose Escalation: Rationale and Current Experience. SAGE Publications, 2011.
Cita MLASemrad, Thomas J., David R. Gandara, y Primo N. Lara. Enhancing the Clinical Activity of Sorafenib Through Dose Escalation: Rationale and Current Experience. SAGE Publications, 2011.
Precaución: Estas citas no son 100% exactas.